Technical Analysis for CDNA - CareDx, Inc.

Grade Last Price % Change Price Change
grade F 23.46 -0.89% -0.21
CDNA closed down 0.89 percent on Tuesday, September 17, 2019, on 51 percent of normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CDNA trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.89%
Crossed Above 20 DMA Bullish -0.89%
Up 3 Days in a Row Strength -0.89%
Up 4 Days in a Row Strength -0.89%
20 DMA Resistance Bearish 5.20%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 5.20%
Lower Bollinger Band Walk Weakness 5.20%
Up 3 Days in a Row Strength 5.20%
Lower Bollinger Band Walk Weakness 6.83%

Older signals for CDNA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. CareDx, Inc. was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in April 2014. The company was incorporated in 1998 and is based in Brisbane, California.
Medicine Medical Specialties Clinical Medicine Gene Expression Organ Transplantation Transplantation Medicine
Is CDNA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 41.27
52 Week Low 19.11
Average Volume 1,005,390
200-Day Moving Average 29.5003
50-Day Moving Average 27.7518
20-Day Moving Average 22.6485
10-Day Moving Average 21.902
Average True Range 1.5716
ADX 24.14
+DI 24.2672
-DI 25.1535
Chandelier Exit (Long, 3 ATRs ) 21.0152
Chandelier Exit (Short, 3 ATRs ) 24.2448
Upper Bollinger Band 25.1886
Lower Bollinger Band 20.1084
Percent B (%b) 0.66
BandWidth 22.430625
MACD Line -1.3674
MACD Signal Line -1.8713
MACD Histogram 0.5039
Fundamentals Value
Market Cap 528.8 Million
Num Shares 22.5 Million
EPS -1.39
Price-to-Earnings (P/E) Ratio -16.88
Price-to-Sales 2.74
Price-to-Book 10.33
PEG Ratio -0.35
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.23
Resistance 3 (R3) 25.29 24.76 24.94
Resistance 2 (R2) 24.76 24.31 24.73 24.84
Resistance 1 (R1) 24.11 24.03 23.85 24.05 24.74
Pivot Point 23.58 23.58 23.45 23.55 23.58
Support 1 (S1) 22.93 23.13 22.67 22.87 22.18
Support 2 (S2) 22.40 22.85 22.37 22.08
Support 3 (S3) 21.75 22.40 21.99
Support 4 (S4) 21.69